
Visby Medical
Founded Year
2012Stage
Series F | AliveTotal Raised
$525.23MLast Raised
$55M | 5 mos agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+135 points in the past 30 days
About Visby Medical
Visby Medical develops polymerase chain reaction (PCR)-based diagnostic tests for the detection of infectious diseases. The company offers medical solutions for sexual health tests, respiratory health tests, and other infectious diseases. It was formerly known as Click Diagnostics. The company was founded in 2012 and is based in San Jose, California.
Loading...
Loading...
Expert Collections containing Visby Medical
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Visby Medical is included in 1 Expert Collection, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,309 items
Visby Medical Patents
Visby Medical has filed 39 patents.
The 3 most popular patent topics include:
- molecular biology
- medical tests
- biotechnology

Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
4/28/2020 | 4/1/2025 | Medical tests, Electronic health records, Blood tests, Molecular biology, Health informatics | Grant |
Application Date | 4/28/2020 |
|---|---|
Grant Date | 4/1/2025 |
Title | |
Related Topics | Medical tests, Electronic health records, Blood tests, Molecular biology, Health informatics |
Status | Grant |
Latest Visby Medical News
Nov 14, 2025
SUNNYVALE, Calif. Nov. 14, 2025 /PRNewswire/ -- Plug and Play, one of the world's most active early-stage investors, announced today an exciting lineup of speakers and innovators for its Silicon Valley November Summit 2025 happening November 18-20 in Sunnyvale. The Summit will feature more than 250 startup debuts (with more than 200 AI firms), which will conduct demos and engage with more than 3,000 attendees, including Fortune 500 decision-makers across dozens of industries. "We accelerate innovation and create impacts because we gather the right people from startups, corporations, investors, and governments," said Saeed Amidi, Founder and CEO of Plug and Play. "Ideas grow into intriguing businesses through our global-spanning events and our global ecosystem. Our goal in this and all summits remains the same, to back founders and push technology forward in all fields." Plug and Play will share locations for its upcoming innovation hubs, new partnerships, and other key initiatives at the summit, reflecting its status as a global innovation hub. The summit highlights how innovation — especially in AI — is transforming every industry and features insights from leaders about managing and capitalizing on change. Participants connect with investors, startup founders, and government leaders while exploring the real-world applications of emerging technologies. Speaker Highlights Amidi and Dennis Cinelli, Chief Financial Officer of Scale AI, will conduct a fireside chat to open the summit as two of the more than 100 speakers at the event. AI-powered agents' impact on the shopping experience will follow, with Fiona Tan, Chief Technology Officer at Wayfair, discussing the ways automation and contextual commerce are changing shoppers' behaviors. Tom Zschach, Chief Information Officer, SWIFT, will also deliver a keynote on how innovation in digital finance can remain open, responsible, and built on trust, bridging the gap between emerging technologies and global financial institutions. Additional speakers include: Tim Draper, Founder and Managing Partner, Draper Associates Casper Vroemen, Chief R&D Officer at IFF Franziska Bossart, Head of AIIF Innovation Fund, Amazon David Warrick, EVP of Overhaul, Former CSCO of Microsoft Peter Matthiesen, Senior Director, Head of Group Innovation and Truck Technology, DSV Jeff Barry, Head of Innovation, Dot Foods Walt Duflock, Vice President of Innovation, Western Growers David Ko, CEO, Calm Dr. Adam de la Zerda, Founder & CEO, Visby Medical Michael Olmstead, Chief Revenue Officer, Plug and Play Amit Patel, Partner, Plug and Play Attendees can learn about the latest trends and innovations in a range of breakout sessions including: State of DefenseTech, Why Arizona Is Your Launchpad for Growth, AI-Ready Data Centers, The State of Stablecoins & XDC Network Startup Program Graduation, Agentic AI with Quantum Computing, along with a venture capital roundtable about Robotics & Physical AI. To learn more about the Summit, visit the Plug and Play event website. About Plug and Play Plug and Play is the leading innovation platform, connecting startups, corporations, venture capital firms, universities, and government agencies. Headquartered in Silicon Valley, we're present in 60+ locations across 25+ industries. We offer corporate innovation programs, helping our partners in every stage of their innovation journey, from education to execution. We also run startup acceleration programs and have built an in-house VC where we've invested in hundreds of successful companies including Dropbox, Guardant Health, Honey, Lending Club, N26, PayPal, and Rappi. For more information, visit Plug and Play. Plug and Play Press Contact Jacky Tsang Senior Communications & PR Associate press@pnptc.com View original content to download multimedia: https://www.prnewswire.com/news-releases/ai-takes-center-stage-at-plug-and-plays-november-summit-with-startups-investors-and-government-leaders-302615203.html SOURCE Plug and Play Back | Next story: Washington Trust adds Clover to its business banking services
Visby Medical Frequently Asked Questions (FAQ)
When was Visby Medical founded?
Visby Medical was founded in 2012.
Where is Visby Medical's headquarters?
Visby Medical's headquarters is located at 3010 North First Street, San Jose.
What is Visby Medical's latest funding round?
Visby Medical's latest funding round is Series F.
How much did Visby Medical raise?
Visby Medical raised a total of $525.23M.
Who are the investors of Visby Medical?
Investors of Visby Medical include John Doerr, Pitango, +ND Capital, Blue Water Life Science Advisors, Cedars-Sinai and 26 more.
Who are Visby Medical's competitors?
Competitors of Visby Medical include Testmate and 2 more.
Loading...
Compare Visby Medical to Competitors
Nostics works as a healthcare technology company specializing in point-of-care diagnostics within the medical diagnostics industry. The company provides pathogen identification solutions that assist healthcare providers in prescribing antibiotics during the initial patient consultation. Nostics' technology utilizes nanotechnology, photonics, and machine learning, producing results. Nostics was formerly known as Spektrax. It was founded in 2020 and is based in Amsterdam, Netherlands.
Testmate specializing in at-home diagnostic testing for sexually transmitted diseases (STDs). The company offers a urine test that provides results for four common STDs, utilizing DNA isothermal technology and Swiss microengineering. Testmate primarily serves individuals seeking convenient and private sexual health testing. Testmate was formerly known as ribolifeDx. It was founded in 2020 and is based in Vaud, Switzerland.

bioMérieux is a company involved in diagnostics in the healthcare sector, particularly in the field of in vitro diagnostics. The company provides products and services for diagnosing infectious diseases, monitoring antimicrobial resistance, and ensuring the quality of pharmaceuticals and food products. bioMérieux's primary customers include healthcare facilities, pharmaceutical manufacturers, and the food industry. It was founded in 1963 and is based in Marcy L'Etoile, France.

Cue Health serves as a healthcare technology company specializing in diagnostic testing within the health sector. The company offers a portable molecular testing platform that provides lab-quality, actionable health insights quickly and conveniently. Cue Health primarily serves the healthcare industry, including clinics and individuals seeking at-home diagnostic solutions. It was founded in 2010 and is based in San Diego, California. In May 2024, Cue Health filed for bankruptcy.

Lucira Health specializes in at-home molecular testing for the healthcare sector. The company offers a test that identifies whether viral respiratory symptoms are due to COVID-19 or the flu, with results available in approximately 30 minutes. This test is for use at home and is available over-the-counter. Lucira Health was formerly known as Diassess. It was founded in 2013 and is based in Emeryville, California. In February 2023, Lucira Health filed for bankruptcy.

Sense Biodetection operates as a molecular diagnostics company. It designs and develops proprietary molecular and device technologies. The company serves hospitals, urgent care, nursing homes, workplace and campus health, community health, and travel sectors. The company was founded in 2014 and is based in Newton, Masssachusetts. In February 2023, Sense Biodetection was acquired by Sherlock Biosciences.
Loading...